Our regulatory network indicates that TGFβ1, also comprised in the smooth muscle differentiation GO term, is controlled by the TFs of the SP family (SP1, SP2, SP4) that are differentially active in PAH patients (Fig. 5d). Here, SP2 is linked to pulmonary arterial hypertension.